Member Info for mulledwine

Some blue here today and again when the FDA approval comes through. Looking good

OUTLOOK The year has started well with positive trends in many of our key markets. Demand from China, our largest market, is strong and we continue to build our presence there and in our other important territories. We remain optimistic that we shall soon receive FDA clearance to commence sales of Aivlosin® in the US, a step which will have a very significant and exciting impact on the development of the company. Overall, Eco is well positioned with an excellent product range, exciting growth opportunities and potentially very important new products in the development phase. The company is poised to accelerate its growth and continue to deliver value to its shareholders.

Peter Lawrence, Executive Chairman of ECO Animal Health Group plc, commented: “ECO Animal Health Group has delivered another strong set of results for the year ended 31 March 2011 and the current year has started well. Demand from China, our largest market, is strong and we continue to build our presence there and in our other important territories. We remain optimistic that we shall soon receive FDA clearance to commence sales of Aivlosin® in the US, a step which will have a very significant and exciting impact on the development of the company. Overall, Eco is well positioned with an excellent product range, exciting growth opportunities and potentially very important new products in the development phase. The company is poised to accelerate its growth and continue to deliver value to its shareholders.”

Results for the year ended 31 March 2011 HIGHLIGHTS Over 16 per cent increase to £6.4 million (2010: £5.5 million) in profit attributable to shareholders before interest, tax, depreciation, amortisation, share based payments, impairment, foreign exchange and minorities. 24.4 per cent advance in turnover on continuing activities to £27.1 million (2010: £21.7 million) 30 per cent uplift in dividend to 3.0 pence per share (2010: 2.3 pence) £8.5 million of cash generated from operating activities during year (2010: £3.3 million) Aivlosin® sales advance over 30 per cent. Over 30 per cent total sales growth in key emerging markets – China, India and Latin America Aivlosin® manufacturing facility approved by US Federal Drug Administration Sales of antiparasitic drugs (Ecomectin®, Ecotraz and others) benefit from increased demand in China, Japan and South Africa and the launch of the Ecomectin® range in Mexico.

http://www.investegate.co.uk/Article.aspx?id=20110722070000Z2392

Additionally, the Board has decided to change reporting currency with immediate effect from the current US dollar to the functional Renminbi in order to eliminate any impact arising from exchange rate movements. Mr. Xiaohong Yang, Executive Chairman said: ""The board remains conscious of fluctuations in crude oil prices and the global economic and political environment which could have some impact on the business. We have generated a profitable performance which strongly reflects the actions we have undertaken to strengthen the business in these challenging conditions. HaiKe has made excellent progress in the strategic move to specialty chemicals; the buyout of Shengli which was immediately earnings enhancing and the establishment of Hebang will further improve intra-group synergies. We believe the focus on higher margin products will make a significant contribution and enhance the long term profitability for the Company as a whole."

HaiKe Chemical Group Ltd Trading Update HaiKe Chemical Group Limited ("HaiKe" or the "Company"), the AIM quoted (AIM: HAIK) petrochemical, specialty chemical and biochemical business based in China, today provides an update on trading ahead of its interim results for the six months period ended 30 June 2011. The Company is pleased to announce that the business continued to perform well in the first half of 2011 and in line with management expectations. The following represent the key points in the Company's trading performance: · The group has recorded strong revenue growth and generated a modest profit compared to significant losses made in H1 2010 · HaiKe's revenues have more than doubled compared to H1 2010, mainly driven by the increase in sales volume as well as an improvement in the selling prices of refined products · The refinery business contributed 89% of total revenues but due to industry wide high feedstock prices margins continued to be squeezed. However, management action to control costs, improve product mix and source readily available feedstock at more favourable prices from the Singapore subsidiary, is having a beneficial impact on the business · Specialty chemical and biochemical contributed 11% of revenues. Both sales volume and selling prices have increased and margins sustained · The Company's strategic focus is on expanding its higher margin chemical products business. As previously announced, HaiKe acquired 29.137% in Shandong Hi-Tech Shengli Electrochemical Co., Ltd. ("Shengli") bringing its total shareholding to 91.45%. The acquisition provides a stable source of income and improves the Company's profitability. In addition, HaiKe has established a new subsidiary, namely Dongying Hebang Chemical Co., Ltd. ("Hebang"), which will produce specialty and salt chemical products. Hebang will further enhance intra-group synergies as it will utilise by-products from existing petrochemical and specialty/salt chemical products. Phase one is now under construction with a total investment of RMB300m (circa GBP29m). It is scheduled to start operation in December 2011.

http://www.investegate.co.uk/Article.aspx?id=201107220700088600K

http://www.investegate.co.uk/Article.aspx?id=20110722070500PEBAE

Norseman Gold Plc. ('Norseman Gold' or 'the Company') Profit Update Norseman Gold, the AIM-listed and ASX-listed Australian gold production company provides the following guidance on its anticipated profit for the year to 30 June 2011, which is currently expected to show a loss of between A$13m and A$14m before tax and abnormal items, with full year gold production of 50,173 ounces. Preliminary results for the full year will be published on or before 31 August 2011. . The fourth quarter of the year saw ore production from the four mines during the quarter increase on previous quarters by some 16% and gold production increase by 27%. The quarter's results were impacted by weather conditions particularly during the last week of the month of June which restricted haulage ability and hence milling throughput and gold production. It is anticipated that the fourth quarter will show a loss of between A$1.5 million and A$2.5 million, a significant improvement over the previous two quarters, which reflects the improved gold production achieved and the impact of the operational changes flagged in April. Free cash flow (cash generated from operations less capital expenditure), while still negative, improved by approximately 65% on the previous quarter. At the end of the year, the Company estimates that it had approximately 2,000 ounces of gold sitting in ore stockpiles, of which 1,600 ounces is in North Royal oxide ore that requires blending, and the remaining 400 ounces is in ore from other sources which is available for immediate processing once it can be transported to the mill. With the improved ore production from the three underground mines, plus the continued good progress with the North Royal open pit, the Company is confident that the finance facility announced on 4 July 2011 will provide sufficient funds if necessary to carry the Company through until North Royal comes into full production, and the fill the mill strategy is realised.

http://www.investegate.co.uk/Article.aspx?id=201107220715018795K

Electronic trading and exchange system provider Patsystems (PTS) has announced the acquisition of Mixit for a maximum consideration of 17.57 million pounds. Patsystems believes the target, a US based execution management systems developer, will contribute to its expansion plans, increasing the group's product range and geographical reach. On the back of a turnover of 9.2 million dollars (5.71 million pounds) for the year ended 31th March 2011, Mixit generated a pre-tax profit of 0.6 million dollars (0.37 million pounds). Patsystems shares inched up 0.25p to 23.25p.

http://www.investegate.co.uk/Article.aspx?id=201107210700127751K

David Wild, Chief Executive Officer, commented: "Halfords is continuing to trade effectively in a difficult environment for UK consumers. Our response to the economic challenges is a clear trading strategy that offers value through great prices, quality, innovative products and expert service. The results can be seen most clearly in our strong cycling sales, where customers have responded favourably to our promotions and new products. Our position is supported by "that's helpful that's halfords", a marketing campaign that reinforces Halfords unique service proposition. We are also pleased with the progress in our Autocentres business. The positive trend in sales has been achieved at a difficult time for motorists when they are reducing mileage. It demonstrates the strength of our proposition and the potential for the Halfords brand to grow in the garage-servicing sector. We remain confident in the cash generation capabilities of the business and with the combination of recommended dividend payments for FY11 together with the share buyback, we will return a total of £120m to shareholders."

http://www.investegate.co.uk/Article.aspx?id=201107210700107704K

Shares in Halfords (HFD) deflated 16p to 341.2p after it released poor results for the 13 weeks ended 1st July, with retail revenues down 0.5% on last year's comparable period, including a 10% fall in car enhancement revenues. However, the auto-parts and bicycle retailer saw a 11.5% increase in like-for-like bike sales and a 7.4% increase in revenues from its autocentres business. Commenting on Halfords, Arden Partners said it is "likely to have to downgrade [its] full year profit before tax [forecast] from 110 million pounds to around 105 million pounds."

Home Retail (HOME) remains a "sell" for Arden Partners and its target price has been cut from 130p to 120p. The broker believes the company will reduce its dividend, which historically would yield 10.7% at the current share price, to yield only 5.4%. Additionally, Arden notes that takeover talks with Asda seem all but forgotten and with little else on the horizon to bolster the group, the broker believes shares will continue to fall. The shares were up 2.8p at 139.6p.

Howden Joinery (HWDN) kept its "buy" rating from Evolution Securities, with a target price of 155p. The broker is impressed with the furniture company's first half results, which saw profits before tax grow to 23.5 million pounds, up 9% on the same period last year. The broker also notes that the company has initiated a 5% price rise on all products in the second half and this has already increased revenue growth to 10.5%, for the start of the period, from 5% in the first half. If this holds Evolution believes it would lead to significant gross profits. Shares in Howden swelled 6.9p to 114.3p.

Arbuthnot Securities reiterated its "buy" recommendation for Hargreaves Services (HSP) with a target price of 1,200p. The broker is encouraged by the coal mining company receiving planning approval for its Tower Colliery project in Wales, which contains 6 million tonnes of coal. The mine could generate revenues of over 60 million pounds per annum, says the broker, as it is well situated to supply a number of large facilities in South Wales. Arbuthnot believes that the shares are cheap, trading at a price-to-earnings multiple of 9. The shares climbed 39p to 1,044p.

888 Holdings (888) retained a "buy" rating from Panmure Gordon, the broker increasing its price target from 47p to 51p. This was after the online gambling company reported revenues of 78.5 million dollars (48.6 million pounds) in its second quarter, significantly ahead of the broker's expectations for 63.4 million dollars (39.3 million pounds). Panmure notes that this represents year on year growth of 28.7% and, furthermore, reports that revenues for the start of the third quarter are averaging 27% higher than in last year's comparable period. The broker believes that this momentum will allow it to report full-year results ahead of market expectations, despite plans for increased investment in the second half of the financial year. The shares jumped 1.5p to 34.5p